Statistical Issues in Drug Development最新文献

筛选
英文 中文
Index 指数
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.index
{"title":"Index","authors":"","doi":"10.1002/9781119238614.index","DOIUrl":"https://doi.org/10.1002/9781119238614.index","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132669424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiplicity 多重性
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch10
{"title":"Multiplicity","authors":"","doi":"10.1002/9781119238614.ch10","DOIUrl":"https://doi.org/10.1002/9781119238614.ch10","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116681079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta‐Analysis 元检测分析
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch16
Jia-Lin Xia, Guang-Lei Li, Hong-En Liu, Feng-Fei Xia, Xin Gu
{"title":"Meta‐Analysis","authors":"Jia-Lin Xia, Guang-Lei Li, Hong-En Liu, Feng-Fei Xia, Xin Gu","doi":"10.1002/9781119238614.ch16","DOIUrl":"https://doi.org/10.1002/9781119238614.ch16","url":null,"abstract":"Background: Both coil embolization (CE) and flow-diverting device (FDD) placement are widely used for treatment of intracranial aneurysms (IAs). The aim of this meta-analysis is to compare the relative clinical safety and efficacy of FDD and CE for the treatment of unruptured IAs. Methods: The PubMed, Embase, and Cochrane Library databases were searched for relevant studies from the date of inception through April 2020. The primary endpoint for this meta-analysis was the 6-month rate of complete occlusion, while secondary endpoints included rates of retreatment, complications, and parental arterial patency. Results:Thismeta-analysis includes 8 studies, which included 839 total patients that underwent FDD and 2734 that underwent CE. FDD group exhibited a significantly higher pooled 6-month complete occlusion rate (P= .02). The subgroup analysis demonstrated that FDD treatment was associated with significantly higher pooled 6-month complete occlusion rates in patients with large or giant IAs (P< .00001), whereas no differences in 6-month complete occlusion rates were observed between the FDD and CE groups of patients with non-large/giant IAs (P= .83). The pooled retreatment (P= .16) and complication (P= .15) rates were comparable between 2 groups. The CE group exhibited significantly higher pooled parent artery patency rate (P= .01). The funnel plots did not reveal any evidence of publication bias. Conclusions: FDDs can be used to effectively and safely treat large and giant IAs, achieving higher rates of complete occlusion than CE treatment. For non-large/giant IAs, we observed comparable efficacy between FDD and CE treatments. Abbreviations: CE = coil embolization, CI = confidence intervals, FDD = flow-diverting device, HR = hazard ratios, IA = intracranial aneurysm, OR = odds ratio.","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"55 20","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113937170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
n ‐of‐1 Trials n‐of‐1个试验
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch18
{"title":"n\u0000 ‐of‐1 Trials","authors":"","doi":"10.1002/9781119238614.ch18","DOIUrl":"https://doi.org/10.1002/9781119238614.ch18","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116127159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross‐Over Trials 交叉检测/试验
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch17
{"title":"Cross‐Over Trials","authors":"","doi":"10.1002/9781119238614.ch17","DOIUrl":"https://doi.org/10.1002/9781119238614.ch17","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"366 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132356392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intention‐to‐Treat, Missing Data and Related Matters 意向治疗、缺失数据和相关事项
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch11
{"title":"Intention‐to‐Treat, Missing Data and Related Matters","authors":"","doi":"10.1002/9781119238614.ch11","DOIUrl":"https://doi.org/10.1002/9781119238614.ch11","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"63 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126109334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose‐Finding
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch20
{"title":"Dose‐Finding","authors":"","doi":"10.1002/9781119238614.ch20","DOIUrl":"https://doi.org/10.1002/9781119238614.ch20","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124416605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Demographic Subgroups 人口结构的子组
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.ch9
{"title":"Demographic Subgroups","authors":"","doi":"10.1002/9781119238614.ch9","DOIUrl":"https://doi.org/10.1002/9781119238614.ch9","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121173070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioequivalence Studies 生物等效性研究
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.5772/33826
A. Qayyum
{"title":"Bioequivalence Studies","authors":"A. Qayyum","doi":"10.5772/33826","DOIUrl":"https://doi.org/10.5772/33826","url":null,"abstract":"During last four decades there is an increased use of generic drug products in order to lower the healthcare cost. With increased availability and use of generic drug products, healthcare professionals are encountered with a large number of multisource products from which they have to select therapeutically equivalent products. Generic substitution is of concern not only for healthcare professionals but also for pharmaceutical industries, consumers and government officials. Many research papers have pointed out the concern regarding standards for approval of generic products which may not always ensure therapeutic equivalence (Boix-Montanes, 2011; Skelly, 2010; Tothfalusi et al., 2009; Midha et al., 2005; Chen & Lesko, 2001; Chen et al., 2000; Strom, 1987; Lamy, 1986). To alleviate this fear many guidelines/guidance and regulations covering the licensing of generic products have been introduced to ensure that the medicinal products reaching the market have well-established efficacy and safety profile (FDA, 1992, 1996, 2001a, 2001b, 2003, 2011; CDSCO, 2005; SFDA, 2005; Health Canada, 2004; CPMP, 2000; WHO, 1986).","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122283630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Glossary 术语表
Statistical Issues in Drug Development Pub Date : 2021-06-02 DOI: 10.1002/9781119238614.gloss
{"title":"Glossary","authors":"","doi":"10.1002/9781119238614.gloss","DOIUrl":"https://doi.org/10.1002/9781119238614.gloss","url":null,"abstract":"","PeriodicalId":319890,"journal":{"name":"Statistical Issues in Drug Development","volume":"52 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132356814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书